Summit Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Summit Financial Group, Inc. holds 10,405 shares of BMY stock, worth $563,742. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,405

Previous 10,430 0.24%

Holding current value

$563,742

Previous $535,000 5.42%

% of portfolio

0.2%

Previous 0.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$47.98 - $54.4 $1,199 - $1,360	-25 Reduced 0.24%	10,405 $564,000
Q4 2023 Jan 12, 2024	SELL	$48.48 - $57.85 $2,424 - $2,892	-50 Reduced 0.48%	10,430 $535,000
Q4 2022 Jan 09, 2023	BUY	$68.48 - $81.09 $54,784 - $64,872	800 Added 8.26%	10,480 $754,000
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $75 - $44,567	580 Added 6.37%	9,680 $688,000
Q1 2022 Apr 08, 2022	SELL	$61.48 - $73.72 $61,480 - $73,720	-1,000 Reduced 9.9%	9,100 $665,000
Q4 2021 Jan 10, 2022	BUY	$53.63 - $62.52 $25,742 - $30,009	480 Added 4.99%	10,100 $630,000
Q2 2021 Jul 06, 2021	BUY	$61.91 - $67.42 $16,715 - $18,203	270 Added 2.89%	9,620 $643,000
Q1 2021 Apr 07, 2021	BUY	$59.34 - $66.74 $59,340 - $66,740	1,000 Added 11.98%	9,350 $590,000
Q2 2020 Jul 06, 2020	SELL	$54.82 - $64.09 $60,302 - $70,499	-1,100 Reduced 11.64%	8,350 $491,000
Q1 2020 Apr 03, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 2.07%	9,450 $527,000
Q4 2019 Jan 06, 2020	SELL	$49.21 - $64.19 $51,818 - $67,592	-1,053 Reduced 9.84%	9,650 $619,000
Q3 2019 Oct 09, 2019	SELL	$42.77 - $50.71 $445,064 - $527,688	-10,406 Reduced 49.3%	10,703 $543,000
Q2 2019 Jul 03, 2019	SELL	$44.62 - $49.34 $10,396 - $11,496	-233 Reduced 1.09%	21,109 $958,000
Q3 2018 Oct 03, 2018	SELL	$55.19 - $62.25 $44,152 - $49,800	-800 Reduced 3.61%	21,342 $1.33 Million
Q2 2018 Jul 03, 2018	SELL	$50.53 - $62.98 $70,742 - $88,172	-1,400 Reduced 5.95%	22,142 $1.23 Million
Q1 2018 Apr 04, 2018	BUY	$59.92 - $68.98 $80,892 - $93,123	1,350 Added 6.08%	23,542 $1.49 Million
Q4 2017 Jan 04, 2018	SELL	$59.94 - $65.35 $4,975 - $5,424	-83 Reduced 0.37%	22,192 $1.36 Million
Q3 2017 Oct 10, 2017	BUY	$55.23 - $63.74 $1.23 Million - $1.42 Million	22,275	22,275 $1.42 Million

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Bristol Myers Squibb CO Transaction History